Amwell Q4 revenue $71M, net loss $44.6M; FY2025 revenue guidance $250-260M, adj EBITDA -$45 to -$55M

American Well Corp

2024-FY EPS reported -$13.88 revenue$254,364,000

Q4 2024: total revenue $71.0M (subscr $36.9M, AMG visits $29.2M), gross margin 48%.
Q4 net loss $44.6M; adj EBITDA -$22.8M, improving from -$31.0M in Q3 2024.
Full-year 2024: revenue $254.4M, net loss $212.6M, adj EBITDA -$134.4M; total visits 5.9M.
FY2025 guidance: revenue $250-260M, adj EBITDA -$55M to -$45M; Q1 rev $59-61M, adj EBITDA -$18 to -$20M.
Cash & short-term securities $228.3M at year-end; targeting positive cash flow in 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.